Zimmer Biomet Holdings, Inc 8-K, filed May 27, 2026
Zimmer Biomet Holdings, Inc. (ZBH)
About this 8-K
Zimmer Biomet Holdings, Inc filed this 8-K on May 27, 2026, reporting on events of May 22, 2026.
Items reported
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
Not applicable |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
|||
|
|
|||
|
|
|||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions:
The vote tabulation for each proposal follows:
Proposal 1 – Election of Directors
Nominee |
For |
Against |
Abstain |
Broker Non-Votes |
Betsy J. Bernard |
162,573,610 |
6,060,594 |
92,412 |
12,009,707 |
Michael J. Farrell |
164,446,421 |
4,180,484 |
99,711 |
12,009,707 |
Robert A. Hagemann |
162,498,257 |
6,126,364 |
101,995 |
12,009,707 |
Arthur J. Higgins |
164,389,482 |
4,236,047 |
101,087 |
12,009,707 |
Maria Teresa Hilado |
163,739,579 |
4,797,047 |
189,990 |
12,009,707 |
Syed Jafry |
165,972,307 |
2,648,596 |
105,713 |
12,009,707 |
Sreelakshmi Kolli |
166,889,697 |
1,734,443 |
102,476 |
12,009,707 |
Devdatt Kurdikar |
160,889,975 |
7,634,226 |
202,415 |
12,009,707 |
Louis A. Shapiro |
167,514,405 |
1,110,244 |
101,967 |
12,009,707 |
Ivan Tornos |
162,652,958 |
5,540,638 |
533,020 |
12,009,707 |
Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm
For |
Against |
Abstain |
Broker Non-Votes |
172,738,361 |
7,887,786 |
110,176 |
0 |
Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation
For |
Against |
Abstain |
Broker Non-Votes |
160,066,066 |
8,386,847 |
273,703 |
12,009,707 |
Proposal 4 – Approval of Shareholder Proposal on Independent Board Chair
For |
Against |
Abstain |
Broker Non-Votes |
31,288,886 |
137,043,058 |
394,672 |
12,009,707 |
Item 9.01 Financial Statements and Exhibits.
EXHIBIT INDEX |
||
Exhibit No. |
|
Description |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 27, 2026
|
ZIMMER BIOMET HOLDINGS, INC. |
|
|
|
|
|
By: |
/s/ Chad F. Phipps |
|
Name: |
Chad F. Phipps |
|
Title: |
Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary |